eGFR cystatin C
Selected indexed studies
- New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. (N Engl J Med, 2021) [PMID:34554658]
- Should Cystatin C eGFR Become Routine Clinical Practice? (Biomolecules, 2023) [PMID:37509111]
- eGFR, cystatin C and creatinine in shrunken pore syndrome. (Clin Chim Acta, 2019) [PMID:31398310]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Cystatin C and eGFR(CKD-EPI-CysC): novel biomarkers for renal impairment diagnosis and two-year progression-free survival in multiple myeloma. (2023) pubmed
- New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. (2021) pubmed
- Should Cystatin C eGFR Become Routine Clinical Practice? (2023) pubmed
- eGFR, cystatin C and creatinine in shrunken pore syndrome. (2019) pubmed
- Association of Cystatin C Kidney Function Measures With Long-term Deficit-Accumulation Frailty Trajectories and Physical Function Decline. (2022) pubmed
- Advantages, Limitations, and Clinical Considerations in Using Cystatin C to Estimate GFR. (2022) pubmed
- Exploring Renal Function Assessment: Creatinine, Cystatin C, and Estimated Glomerular Filtration Rate Focused on the European Kidney Function Consortium Equation. (2024) pubmed
- Estimating eGFR using serum creatinine or cystatin C in healthy Vietnamese population. (2024) pubmed
- A Meta-Analysis on the Performance of Cystatin C- versus Creatinine-based eGFR Equations in Predicting Vancomycin Clearance. (2020) pubmed
- Concordance between creatinine- and cystatin C-based eGFR in clinical practice. (2021) pubmed